Trevi Therapeutics
TRVI
TRVI
163 hedge funds and large institutions have $1.18B invested in Trevi Therapeutics in 2025 Q3 according to their latest regulatory filings, with 34 funds opening new positions, 65 increasing their positions, 42 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
7% more funds holding
Funds holding: 153 → 163 (+10)
14% less funds holding in top 10
Funds holding in top 10: 7 → 6 (-1)
48% less call options, than puts
Call options by funds: $8.43M | Put options by funds: $16.3M
Holders
163
Holding in Top 10
6
Calls
$8.43M
Puts
$16.3M
Top Buyers
| 1 | +$32.8M | |
| 2 | +$30M | |
| 3 | +$28.2M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$26.8M |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$21.6M |
Top Sellers
| 1 | -$36.1M | |
| 2 | -$15.8M | |
| 3 | -$12.8M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$11.1M |
| 5 |
OCA
Octagon Capital Advisors
New York
|
-$7.84M |
